| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.53B | 70.72B | 65.03B | 65.45B | 58.87B | 113.03B |
| Gross Profit | 9.75B | 9.27B | 7.03B | 7.11B | 8.10B | 7.72B |
| EBITDA | 3.89B | 4.16B | 1.45B | 2.42B | 3.12B | 3.34B |
| Net Income | 2.31B | 2.16B | -1.58B | -4.96B | 1.15B | 1.83B |
Balance Sheet | ||||||
| Total Assets | 75.15B | 84.59B | 80.80B | 76.06B | 90.90B | 75.78B |
| Cash, Cash Equivalents and Short-Term Investments | 15.28B | 16.15B | 11.29B | 8.15B | 8.68B | 9.24B |
| Total Debt | 13.23B | 13.72B | 20.15B | 16.75B | 14.75B | 16.10B |
| Total Liabilities | 53.18B | 63.59B | 60.91B | 54.86B | 64.10B | 48.80B |
| Stockholders Equity | 21.94B | 20.98B | 19.85B | 21.20B | 26.80B | 26.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.95B | -444.00M | -1.87B | -2.18B | -6.76B |
| Operating Cash Flow | 0.00 | 5.35B | 12.00M | -1.40B | -1.30B | -2.79B |
| Investing Cash Flow | 0.00 | 1.71B | 575.00M | -408.00M | -1.01B | 1.01B |
| Financing Cash Flow | 0.00 | -7.50B | 2.23B | 1.26B | 1.18B | 3.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥42.91B | 16.86 | ― | 3.48% | 18.42% | 51.06% | |
78 Outperform | ¥306.41B | 7.92 | 11.34% | 3.38% | 3.44% | 6.97% | |
78 Outperform | ¥42.48B | 7.95 | ― | 1.90% | 12.47% | 21.98% | |
74 Outperform | ¥23.90B | 3.83 | ― | 3.66% | -18.88% | 42.17% | |
73 Outperform | ¥99.54B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
73 Outperform | ¥357.79B | 9.25 | ― | 3.13% | 1.50% | 9.82% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |